Literature DB >> 11380431

The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.

S Middeldorp1, E J Libourel, K Hamulyák, J Van der Meer, H R Büller.   

Abstract

The risk of venous thromboembolism (VTE) is increased in pregnancy and during the post-partum period. The absolute risk for pregnancy-related VTE in heterozygous women with the factor V Leiden mutation is approximately 2%, but studies on this risk for homozygous women show conflicting results. In a retrospective family study, we found that the risk of pregnancy-related VTE in women with a symptomatic first-degree relative was 17% per pregnancy (95%CI 4.7-37.4). Anticoagulant prophylaxis during the post-partum period appears to be indicated in asymptomatic homozygous women from symptomatic kindred, whereas this could be decided on an individual basis during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380431     DOI: 10.1046/j.1365-2141.2001.02766.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Inherited thrombophilia and pregnancy associated venous thromboembolism.

Authors:  Wendy Lim; John W Eikelboom; Jeffrey S Ginsberg
Journal:  BMJ       Date:  2007-06-23

3.  Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.

Authors:  Ymir Saemundsson; Signý Vala Sveinsdottir; Henrik Svantesson; Peter J Svensson
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

Review 4.  Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 5.  Testing for thrombophilia: an evidence-based approach.

Authors:  L Merriman; M Greaves
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

6.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Authors:  Shannon M Bates; Anita Rajasekhar; Saskia Middeldorp; Claire McLintock; Marc A Rodger; Andra H James; Sara R Vazquez; Ian A Greer; John J Riva; Meha Bhatt; Nicole Schwab; Danielle Barrett; Andrea LaHaye; Bram Rochwerg
Journal:  Blood Adv       Date:  2018-11-27

7.  Venous thromboembolism in pregnancy.

Authors:  Marcelo P Villa-Forte Gomes
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-04

Review 8.  Pulmonary embolism in pregnancy.

Authors:  E Conti; L Zezza; E Ralli; C Comito; L Sada; J Passerini; D Caserta; S Rubattu; C Autore; M Moscarini; M Volpe
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

9.  Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium.

Authors:  Andrea Gerhardt; Rüdiger E Scharf; Ian A Greer; Rainer B Zotz
Journal:  Blood       Date:  2016-09-09       Impact factor: 22.113

Review 10.  Evidence-based approach to thrombophilia testing.

Authors:  Saskia Middeldorp
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.